Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vernal Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Vernal Biosciences

Vernal Biosciences

Vernal Biosciences: High-purity mRNA manufacturing from concept to clinical trials.

HQ
Burlington, VT, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Vernal Biosciences, founded with a mission to advance mRNA technology, specializes in the high-purity manufacturing of mRNA from concept to clinical trials. The company offers a range of services including mRNA sequence design, custom mRNA production, GMP mRNA, and LNP-formulated mRNA manufacturing. Their market focus is on providing transactional mRNA solutions to support various stages of drug development and clinical research.

Notable figures associated with Vernal Biosciences include experts in biotechnology and pharmaceutical manufacturing. The company has achieved significant milestones in producing high-quality mRNA for clinical applications, contributing to advancements in therapeutic and vaccine development. Vernal Biosciences' impact is marked by its role in accelerating the availability of mRNA-based solutions, thereby supporting innovation in the biotech industry.

Vernal Biosciences - Similar Companies

Sensible Biotechnologies logo

Sensible Biotechnologies

sensible.bio

Rnaimmune logo

Rnaimmune

rnaimmune.com

Cisterna Biologics logo

Cisterna Biologics

cisternabx.com

Engage Bio logo

Engage Bio

Moderna logo

Moderna

modernatx.com

VintaBio logo

VintaBio

vintabio.com

EnPlusOne Biosciences logo

EnPlusOne Biosciences

enplusonebio.com

Andelyn Biosciences logo

Andelyn Biosciences

andelynbio.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Mana.bio logo

Mana.bio

mana.bio

Verda Bio logo

Verda Bio

verdabio.com

Verve Therapeutics logo

Verve Therapeutics

vervetx.com

Rnav8 Bio logo

Rnav8 Bio

Vector Biomed logo

Vector Biomed

vectorbiomed.com

Inceptive logo

Inceptive

inceptive.life

Vernal Biosciences - Quick Facts

Who are Vernal Biosciences' competitors?

Companies similar to Vernal Biosciences include Sensible Biotechnologies, Rnaimmune, Cisterna Biologics and Engage Bio.

When was Vernal Biosciences founded?

Vernal Biosciences was founded in 2021.

Where is Vernal Biosciences' headquarters located?

Vernal Biosciences' headquarters is located in Burlington, VT, US.

When was Vernal Biosciences' last funding round?

Vernal Biosciences' most recent funding round was for $20M (USD) in June 2023.

How much has Vernal Biosciences raised to-date?

As of Jun 27, 2023, Vernal Biosciences has raised a total of $41M (USD).

How many employees does Vernal Biosciences have?

Vernal Biosciences has 75 employees as of Feb 5, 2024.

Vernal Biosciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Mrna Manufacturing
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified